Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients

Convalescent plasma (CP) have been used for treatment of coronavirus disease 2019 (COVID-19), but their effectiveness varies significantly. Moreover, the impact of CP treatment on the composition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in COVID-19 patients and anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Juanjie, Grubbs, Gabrielle, Lee, Youri, Golding, Hana, Khurana, Surender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083369/
https://www.ncbi.nlm.nih.gov/pubmed/33861337
http://dx.doi.org/10.1093/cid/ciab317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083369/
https://www.ncbi.nlm.nih.gov/pubmed/33861337
http://dx.doi.org/10.1093/cid/ciab317

Ejemplares similares